Intrepid Family Office LLC has made a significant move by acquiring 110,000 shares of HeartFlow (HTFL), valued at approximately $2.99 million, according to an SEC filing from May 15, 2026. This new position now represents 2.16% of Intrepid’s reportable assets, indicating a bullish outlook on the healthcare technology company specializing in AI-driven cardiac diagnostics.
The investment comes at a pivotal time as HeartFlow’s shares have rebounded from a 52-week low of $20.13 in February, with a notable 41% year-over-year revenue increase to $52.6 million reported in Q1. Despite still operating at a net loss of $27.4 million, the company boasts a solid balance sheet, with total assets significantly exceeding liabilities. The stock’s price-to-sales ratio has risen to 14, suggesting potential for further growth, although it remains lower than last year’s ratio of 18.
For market professionals, Intrepid’s investment underscores a growing confidence in HeartFlow’s ability to leverage its innovative diagnostic solutions for sustained revenue growth, making it a stock to watch for potential upside as the company aims for profitability.
Source: fool.com